The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[(3S*R*,Z)-3-((3S*R*,E)-3-Hydroxy-7-phenyl-1-hepten-1-yl)cyclohexylidene]-N,N-dimethyl-acetamide ID: ALA264039
PubChem CID: 44366652
Max Phase: Preclinical
Molecular Formula: C23H33NO3
Molecular Weight: 371.52
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)OC(=O)/C=C1/CCC[C@H](/C=C/C(O)CCCCc2ccccc2)C1
Standard InChI: InChI=1S/C23H33NO3/c1-24(2)27-23(26)18-21-13-8-12-20(17-21)15-16-22(25)14-7-6-11-19-9-4-3-5-10-19/h3-5,9-10,15-16,18,20,22,25H,6-8,11-14,17H2,1-2H3/b16-15+,21-18-/t20-,22?/m1/s1
Standard InChI Key: GROGAXYRPIVKQC-GJFTZNTESA-N
Molfile:
RDKit 2D
27 28 0 0 1 0 0 0 0 0999 V2000
4.1042 -0.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5875 -0.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5875 -1.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6292 -2.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1500 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1042 -0.0667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6292 -0.9667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6250 0.2333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1042 -1.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1042 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6667 -2.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0750 -1.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2667 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6667 -3.3750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0750 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6250 0.8333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1417 -0.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5875 -2.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7417 -2.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2625 -1.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7792 -2.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1875 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2292 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7042 -2.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3042 -2.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7792 -1.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3042 -1.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
10 4 1 1
5 4 2 0
6 1 1 0
7 1 2 0
8 6 1 0
9 3 1 0
10 9 1 0
11 5 1 0
12 3 1 0
13 19 1 0
14 11 1 0
15 12 1 0
16 8 1 0
17 8 1 0
18 15 1 0
19 23 1 0
20 13 1 0
21 13 2 0
22 11 1 0
23 24 1 0
24 22 1 0
25 21 1 0
26 20 2 0
27 25 2 0
10 18 1 0
27 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 371.52Molecular Weight (Monoisotopic): 371.2460AlogP: 4.45#Rotatable Bonds: 9Polar Surface Area: 49.77Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.22CX LogP: 5.00CX LogD: 5.00Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.30Np Likeness Score: 0.75
References 1. Poudrel JM, Hullot P, Vidal JP, Girard JP, Rossi JC, Muller A, Bonne C, Bezuglov V, Serkov I, Renard P, Pfeiffer B.. (1999) Synthesis and structure-activity relationships of new 1, 3-disubstituted cyclohexanes as structurally rigid leukotriene B(4) receptor antagonists., 42 (26): [PMID:10639274 ] [10.1021/jm9910573 ]